Aller au contenu principal
Profil bibliographique

Mark O. Dimitry

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

10Publications signalées
18Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular HealthAdipokines, Inflammation, and Metabolic DiseasesPulmonary Hypertension Research and TreatmentsMicroRNA in disease regulation

Les publications récentes

Accès ouvert 2026 article OpenAlex

Circulating miR-16-5p and miR-21-5p in the early post-acute interval of acute myocardial infarction: phase-specific expression and early clinical assessment

Mark O. Dimitry, Solaf Ahmed Kamel, Eman Mahmoud Hassan, Rasha Nazih et autres

Abstract Background microRNAs show dynamic responses after acute myocardial infarction (AMI). The early post-acute interval (24–48 h after symptom onset) represents a transition from acute injury to early inflammatory signaling and constitutes a clinically relevant interval in which ventricular function and clinical …

Égypte (code pays fourni par la source)

0 citations Bulletin of the National Research Centre/Bulletin of the National Research Center
Accès ouvert 2026 other OpenAlex

Genomic and clinical predictors of cardiovascular disease in Familial dyslipidemia: risk stratification in Egyptian adolescents and young adults

Ammal Mokhtar Metwally, Nesma Mohamed Elaraby, Wafaa Mohamed Ezzat, Mark O. Dimitry et autres

Abstract Familial dyslipidemia (FD), particularly familial hypercholesterolemia (FH), is a major contributor to premature cardiovascular disease (CVD), especially in regions with high consanguinity and underutilized genetic screening, such as Egypt. This study aimed to assess clinical, biochemical, and genetic factors that differentiate …

Égypte, us (code pays fourni par la source)

0 citations Figshare
Accès ouvert 2026 other OpenAlex

Genomic and clinical predictors of cardiovascular disease in Familial dyslipidemia: risk stratification in Egyptian adolescents and young adults

Ammal Mokhtar Metwally, Nesma Mohamed Elaraby, Wafaa Mohamed Ezzat, Mark O. Dimitry et autres

Abstract Familial dyslipidemia (FD), particularly familial hypercholesterolemia (FH), is a major contributor to premature cardiovascular disease (CVD), especially in regions with high consanguinity and underutilized genetic screening, such as Egypt. This study aimed to assess clinical, biochemical, and genetic factors that differentiate …

Égypte, us (code pays fourni par la source)

0 citations Figshare
Accès ouvert 2025 article OpenAlex

Genomic and clinical predictors of cardiovascular disease in Familial dyslipidemia: risk stratification in Egyptian adolescents and young adults

Ammal Mokhtar Metwally, Nesma Mohamed Elaraby, Wafaa Mohamed Ezzat, Mark O. Dimitry et autres

Familial dyslipidemia (FD), particularly familial hypercholesterolemia (FH), is a major contributor to premature cardiovascular disease (CVD), especially in regions with high consanguinity and underutilized genetic screening, such as Egypt. This study aimed to assess clinical, biochemical, and genetic factors that differentiate FD …

Égypte, us (code pays fourni par la source)

0 citations Lipids in Health and Disease
Accès ouvert 2024 article OpenAlex

Role and predictive value of microRNAs 204 and 210 in the diagnosis of pulmonary arterial hypertension and the distinction between idiopathic, systemic sclerosis, and schistosomiasis-associated pulmonary arterial hypertension

Mark O. Dimitry, Yosef M. Amin, Reem Ibrahim Elkorashy, Hala M. Raslan et autres

Abstract Background Pulmonary arterial hypertension is most of the time diagnosed late in the course of the disease and necessitates right cardiac catheterization which is an invasive and costly tool. MicroRNAs have a role in the pathogenesis of pulmonary hypertension, systemic sclerosis, …

Égypte (code pays fourni par la source)

3 citations Egyptian Journal of Bronchology
Accès ouvert 2023 article OpenAlex

Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension

Mark O. Dimitry, Youssef Mohamed Amin Soliman, Reem Ibrahim Elkorashy, Hala M. Raslan et autres

BACKGROUND: Pulmonary hypertension "PH" is considered a serious cardiovascular disease. World Health Organization divided PH into groups depending on many factors like pathological, hemodynamic, and clinical pictures. Lately, various micro-RNAs "miRNAs" and other novel biomarkers like endoglin and asymmetric dimethylarginine "ADMA" might …

Égypte (code pays fourni par la source)

3 citations The Egyptian Heart Journal
Accès ouvert 2021 article OpenAlex

Role of Some Serum Biomarkers in the Early Detection of Diabetic Cardiomyopathy

Amany H. Abdelrahman, Iman I. Salama, Somaia I Salama, Dalia M. Elmosalami et autres

AIM: To assess the role of serum biomarkers in early prediction of diabetic cardiomyopathy. MATERIALS AND METHODS: The participants were three groups of Type 2 diabetes mellitus (DM) patients having diastolic dysfunction (DM-DD), systolic dysfunction (DM-SD) and normal echocardiography (DM-N) with two …

Égypte (code pays fourni par la source)

12 citations Future Science OA

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.